Abstract
Aim
Aims of these study are to determine the three years survival rate of COPD patients who were hospitalized for acute exacerbation and to determine the factors that may be affect the survival rate.
Material and methods
The patients who admitted to hospital for acute exacerbation of COPD (AECOPD) and were included the ERS COPD audit study in 2009 from Zonguldak, Turkey were eligible for this study. Descriptive data of patients were reviewed. Three years survival rates of patients, hospitalisation frequency, duration of hospitalisation and current therapies for COPD were investigated.
Results
56 patients (37 male, 19 female) whose mean age was 70,1 were included to study. Death rates of AECOPD patients for 90 days , one year and three years after the exacerbation were 44,6% , 53,6% and 66,0%, respectively. There was no significant difference between groups in terms of long term oxigen therapy, hypercapnea, age, gender, mean FEV1 % of predicted.
mean duration of hospitalisation and number of hospitalisation of patients who survived three years were 82 days and 6,7i, respectively.
Discussion
Long term survival rate of AECOPD patients after an exacerbation that requires hospitalisation was low (34%). Exacerbation is an important factor that affects mortality and morbidity in patients with COPD.
- © 2014 ERS